WANY
WVE icon

Wealthspire Advisors (New York)’s Wave Life Sciences WVE Stock Holding History

Wealthspire Advisors (New York)’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,350
Closed -$9.88K – 2923
2025
Q3 		$9.88K Buy
+1,350
New +$10.9K ﹤0.01% 2021

Other funds holding WVE

GP
GSK plc London $602M AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return

Wealthspire Advisors (New York)'s WVE Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Wave Life Sciences (WVE) in Q4 2025, closing a stake of 1,350 shares — an estimated $9.88K sold.

Wealthspire Advisors (New York) first reported a position in WVE in Q3 2025 and held it in 1 quarter. The position peaked at $9.88K in Q3 2025. 218 funds tracked by Wall St. Rank hold WVE as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Wave Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 1,350 Wave Life Sciences shares in Q4 2025, an estimated $9.88K.
  • Wealthspire Advisors (New York) first reported a position in Wave Life Sciences in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Wave Life Sciences position peaked at $9.88K in Q3 2025.
  • 218 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.